Demian says that lipotropic injections may have a mild effect on weight loss
Beyond pancreatic effects, GLP-1R agonists exert widespread extra-pancreatic benefits, attributed to the extensive distribution of GLP-1R in different organs, including gastrointestinal tract, kidneys, liver, skeletal and smooth muscle, neural tract, adipose tissue, and the cardiovascular system, where they are expressed in endothelial cells, vascular smooth muscle, cardiomyocytes, and different inflammatory cells [20], underpinning the synthetic GLP-1 and GLP-1RAs associated cardiovascular benefits observed in clinics [21]
#ObesityMedicine #Retatrutide #EliLilly #MetabolicHealth #MedicalInnovation #Endocrinology #WeightLoss To view or add a comment, sign in More Relevant Posts REDEFINE 1 Signals a New Era for Obesity Pharmacotherapy The REDEFINE 1 trial offers a clear signal that combination therapies may redefine expectations for medical weight loss
Similarly, Jia et al (91) reported that elevated neuronal lactate uptake augments ROS production and mitochondrial oxidative metabolism, thereby disrupting the balance between ROS generation and detoxification, impairing ATP synthesis and ultimately leading to peripheral axonal degeneration
.png)
